Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
Hulse
G K
GK
Unit for Research and Education in Drugs and Alcohol, University of Western Australia, School of Psychiatry & Clinical Neurosciences, Perth, Australia. ghulse@cyllene.uwa.edu.au
O'Neil
G
G
Arnold-Reed
D E
DE
D001315:Australia; D004343:Drug Implants; D005260:Female; D006556:Heroin Dependence / Q000188:drug therapy*; D006801:Humans; D008691:Methadone / Q000627:therapeutic use*; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009294:Narcotics / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome
D004343:Drug Implants; D009292:Narcotic Antagonists; D009294:Narcotics; D009271:Naltrexone; D008691:Methadone